Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04436224
PHASE4

Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation

Sponsor: Nanfang Hospital, Southern Medical University

View on ClinicalTrials.gov

Summary

Hydromorphone has a clear analgesic effect, and has few advantages in respiratory depression and gastrointestinal motility. The study will further explore the continuous pumping-dose of hydromorphone for ICU non-mechanical ventilation patients and monitor its effective plasma concentration as well as evaluates the safety and effectiveness of hydromorphone for ICU non-mechanical ventilation patients.

Official title: Hydromorphone for ICU-analgesia in Patients With Non-mechanical Ventilation: A Dose-exploration and Effectiveness Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

530

Start Date

2020-09-04

Completion Date

2025-05-30

Last Updated

2026-09-02

Healthy Volunteers

No

Interventions

DRUG

Hydromorphone

Intravenous analgesia using hydromorphone in ICU patients with non-mechanical ventilation(NS 40ML+ hydromorphone 10mg ,IV-Pump)

DRUG

Fentanyl

Intravenous analgesia using fentanyl in ICU patients with non-mechanical ventilation(NS 40ML+ fentanyl 0.5mg, IV-Pump)

DRUG

Butorphanol

Intravenous analgesia using butorphanol in ICU patients with non-mechanical ventilation(NS 40ML+ butorphanol 10mg,IV-Pump)

Locations (1)

Southern medical university Nanfang hospital

Guangzhou, China